Molecular detection of cytokeratin-19-positive cells in the peripheral blood of patients with operable breast cancer: Evaluation of their prognostic significance

Journal of Clinical Oncology

Volumn 20, Issue 16, 2002, Pages 3404-3412

  Stathopoulou, A ^a   Vlachonikolis, I ^a   Mavroudis, D ^a   Perraki, M ^a   Kouroussis, Ch ^a   Apostolaki, S ^a   Malamos, N ^a   Kakolyris, S ^a   Kotsakis, A ^a   Xenidis, N ^a   Reppa, D ^a   Georgoulias, V ^a  

^a UNIVERSITY OF CRETE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN 19; MESSENGER RNA;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; BREAST CANCER; CANCER STAGING; CANCER SURVIVAL; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MOLECULAR BIOLOGY; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; ANALYSIS OF VARIANCE; BREAST NEOPLASMS; CASE-CONTROL STUDIES; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KERATINS; LOGISTIC MODELS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 0037102125     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2002.08.135     Document Type: Article

References (49)

1. Relation of tumor size, lymph node status, and survival in 24740 breast cancer cases
2. Breast cancer prognostic factors: Evaluation guidelines
3. Meeting highlights: International consensus panel on the treatment of primary breast cancer
4. Breast cancer therapy: Exercising all our options
5. Postoperative radiotherapy in high-risk premenopausal women with breast cancer
6. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer
7. The detection of minimal numbers of contaminating epithelial tumor cells in blood or bone marrow: Use, limitations and future of RNA-based methods
8. Detection and clinical importance of micrometastatic disease
9. Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases
10. Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II or III breast cancer
11. Micrometastatic breast cancer cells in bone marrow at primary surgery: Prognostic value in comparison with nodal status
12. Bone marrow micrometastases in primary breast cancer: Prognostic significance after 6 years' follow up
13. Clinical significance of bone marrow metastases as detected using the polymerase chain reaction in patients with breast cancer undergoing high-dose chemotherapy and autologous bone marrow transplantation
14. Tumour cell detection in the bone marrow of breast cancer patients at primary therapy: Results of a 3-year median follow-up
15. Meta-analyses of studies on bone marrow micrometastases: An independent prognostic impact remains to be substantiated
16. Immunohistochemical detection of occult carcinoma in bone marrow and blood: Critical analysis of efficiency of separation, preparation and limits of detection in a model system
17. Methodological analysis of immunocytochemical screening for disseminated epithelial tumor cells in bone marrow
18. Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction
19. The detection of micrometastases in the peripheral blood and bone marrow of patients with breast cancer using immunohistochemistry and reverse transcriptase polymerase chain reaction for keratin 19
20. Evaluation of breast tumor cell contamination in the bone marrow and leukapheresis collections by RT-PCR for cytokeratin-19
21. Quantitative polymerase chain reaction for the detection of micrometastases in patients with breast cancer
22. Analysis of sensitivity and specificity of cytokeratin 19 reverse transcriptase-polymerase chain reaction for the detection of occult breast cancer in bone marrow and leukapheresis products
23. Lack of effect of adjuvant chemotherapy on the elimination of single dormant tumor cells in the bone marrow of high-risk breast cancer patients
24. Comparative analysis of micrometastasis to the bone marrow and lymph nodes of node-negative breast cancer patients receiving no adjuvant chemotherapy
25. Low specificity of cytokeratin 19 reverse transcriptase-polymerase chain reaction analyses for detection of hematogenous lung cancer dissemination
26. Detection of epithelial cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction
27. High-sensitivity detection of minimal residual breast carcinoma using the polymerase chain reaction and primers for cytokeratin-19
28. Reverse transcriptase-polymerase chain reaction detection of cytokeratin-19 mRNA in bone marrow and blood of breast cancer patients
29. Keratin gene expression in non-epithelial tissues: Detection with polymerase chain reaction
30. Detection of rare human breast cancer cells: Comparison of an immunomagnetic separation method with immunochemistry and RT-PCR
31. Molecular detection of cancer cells in bone marrow and peripheral blood of patients with operable breast cancer: Comparison of CK-19, MUC1 and CEA using RT-PCR
32. Detection and quantitation of circulating cancer cells in the peripheral blood of lung cancer patients
33. Putative markers for the detection of breast carcinoma cells in blood
34. Detection of breast cancer micrometastases in axillary lymph nodes by using polymerase chain reaction
35. Identification of a novel cytokeratin 19 pseudogene that may interfere with reverse transcriptase-polymerase chain reaction assays used to detect micrometastatic tumor cells
36. High percentage of false-positive results of cytokeratin 19 RT-PCR in blood: A model for the analysis of illegitimate gene expression
37. Reverse transcriptase-polymerase chain reaction analysis of cytokeratin 19 expression in the peripheral blood mononuclear cells of normal female blood donors
38. Specificity of reverse transcriptase polymerase chain reaction assays designed for the detection of circulating cancer cells is influenced by cytokines in vivo and in vitro
39. Illegitime transcription: Transcription of any gene in any cell type
40. Primers are decisive for sensitivity of PCR
41. Detection of circulating tumour cells in patients with breast or ovarian cancer by molecular cytogenetics
42. Detection of genetic alterations in micrometastatic cells in bone marrow of cancer patients by fluorescence in situ hybridization
43. Reduction of metastatic carcinoma cells in bone marrow by intravenously administered monoclonal antibody: Towards a novel surrogate test to monitor adjuvant therapies of solid tumours
44. Monoclonal antibody therapy with edrecolomab in breast cancer patients: Monitoring of elimination of disseminated cytokeratin-positive tumor cells in bone marrow